Accumulating evidence from previous investigations has underscored the substantial elevation of IMPDH2 expression, which correlates closely with tumor progression and a poor prognosis in a diverse array of malignancies (Zhou et al. 2014). The gene discussed is IMPDH2; the disease is neoplasm.